Drug Profile
SGS 111
Alternative Names: DVD111; SGS111Latest Information Update: 23 May 2006
Price :
$50
*
At a glance
- Originator Russian Academy of Medical Sciences
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported CNS trauma; Cognition disorders; Stroke
Most Recent Events
- 12 May 2006 No development reported - Phase-II for Cognition disorders in USA (PO)
- 12 May 2006 No development reported - Phase-I/II for CNS trauma in USA (PO)
- 12 May 2006 No development reported - Phase-I/II for Stroke in USA (PO)